REVO's selling the patent rights - not licensing them. A sale of rights transfers ownership. A licensing of rights retains ownership. It's an important legal difference, with big financial consequences. REVO has filed notice of a sale of the patent rights.
There's no asset left in the REVO balance sheet when the asset is sold.
The sale of "substantially all" of REVO's assets requires approval by a vote of the preferrence shareholders. Which is why the proxy filing is being made with the SEC. The non-exclusive licensing of the assets does not require a vote.
Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.